Child Psychiatry

Wednesdays, noon - 1 p.m.

4/7/2021

This 12-session ECHO series will help enhance the ability of primary care clinicians throughout the state to identify and treat mental health issues in children. Both pharmacological and non-pharmacological treatment methods will be presented. Topics will include: 

  • ADHD
  • Anxiety Disorder
  • Depression
  • Learning Disabilities
  • Trauma
  • Post-Traumatic Stress Disorder

We will select 15-20 clinical teams to participate. Clinical teams will include at least one prescribing clinician (MD, DO, ND, PA, NP, PMHNP) and up to two other supporting staff, which could include a behavioral health provider, pharmacist, nurse care manager, or medical assistant. Practices with integrated behavioral health specialists are especially encouraged to register

Accreditation: Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit: OHSU School of Medicine designates this live activity for a maximum 12.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program is registered for MOC through the American Board of Internal Medicine (ABIM) and the American Board of Pediatrics (ABP)

Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Child Psychiatry has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards: Family Medicine, Psychiatry and Neurology.

FACULTY DISCLOSURE INFORMATION
In accordance with the requirements of the Standards for Commercial Support of the Accreditation Council for Continuing Medical Education, each instructor and member of the planning committee has been asked to disclose any relevant financial relationships with commercial interests (defined as: any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients). The information disclosed for this activity is listed below.

PROGRAM PLANNING COMMITTEE

  • Keith Cheng, MD has Nothing to Disclose
  • Teri Petterson, MD has Nothing to Disclose

Instructors/Moderators

  • Tamara Bakewell, MA, has Nothing to Disclose
  • Keith Cheng, MD, has Nothing to Disclose
  • Ajit Jetmalani, M.D., has Nothing to Disclose
  • Rebecca Marshall, M.D., has Nothing to Disclose
  • Teri Petterson, MD, has Nothing to Disclose
  • Kara Lee Shirley, PharmD, has Nothing to Disclose
  • Craigan Usher, M.D., has Nothing to Disclose

6/23/2021


Session/Title Date
0 - General Resources 3/1/2021
1 - Assessment Essentials and Case Formulation 4/7/2021
2 - Measurement-based Care Through Rating Scales 4/14/2021
3 - ADHD vs PTSD 4/21/2021
4 - When Should Your Patient get Genetic Testing 4/28/2021
5 - Suicide Risk Evaluations 5/5/2021
6 - When Deprescribing is Indicated 5/12/2021
7 - High Functioning Autism vs Learning Disorder 5/19/2021
8 - Major Depression vs Eating Disorder 5/26/2021
9 - Anxiety Disorders vs Substance Use Disorder (SUD) 6/2/2021
10 - Psychosis 6/9/2021
11 - When Do Off-label Prescriptions Make Sense 6/16/2021
12 - Non-medical Interventions to Use in the Medical Home 6/23/2021
Sign Up For This ECHO